Aberrant expression of retinoic acid signaling molecules influences patient survival in astrocytic gliomas

American Journal of Pathology

Volumn 178, Issue 5, 2011, Pages 1953-1964

  Campos, Benito ^a   Centner, Franz Simon ^a   Bermejo, Justo Lorenzo ^b,c   Ali, Ramadan ^a   Dorsch, Katharina ^a   Wan, Feng ^a,d   Felsberg, Jörg ^e   Ahmadi, Rezvan ^a   Grabe, Niels ^a   Reifenberger, Guido ^e   Unterberg, Andreas ^a   Burhenne, Jürgen ^a   Herold Mende, Christel ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDH1A1 PROTEIN; CRABP2 PROTEIN; CRBP1 PROTEIN; CYP26B1 PROTEIN; FABP5 PROTEIN; PROTEIN; RETINOIC ACID; RETINOID; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CONCENTRATION (PARAMETERS); CORRELATIONAL STUDY; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL; TUMOR CELL; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 79959282770     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.01.051     Document Type: Article

References (45)

1. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760 (Pubitemid 44949604)
2. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828 (Pubitemid 37187480)
3. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD, Dirks PB: Identification of human brain tumour initiating cells. Nature 2004, 432:396-401 (Pubitemid 39551674)
4. Henion PD, Weston JA: Retinoic acid selectively promotes the survival and proliferation of neurogenic precursors in cultured neural crest cell populations. Dev Biol 1994, 161:243-250 (Pubitemid 24049171)
5. Plum LA, Parada LF, Tsoulfas P, Clagett-Dame M: Retinoic acid combined with neurotrophin-3 enhances the survival and neurite outgrowth of embryonic sympathetic neurons. Exp Biol Med (Maywood) 2001, 226:766-775 (Pubitemid 32785973)
6. Jacobs S, Lie DC, DeCicco KL, Shi Y, DeLuca LM, Gage FH, Evans RM: Retinoic acid is required early during adult neurogenesis in the dentate gyrus. Proc Natl Acad Sci USA 2006, 103:3902-3907 (Pubitemid 43376653)
7. Esteller M, Guo M, Moreno V, Peinado MA, Capella G, Galm O, Baylin SB, Herman JG: Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer. Cancer Res 2002, 62:5902-5905 (Pubitemid 35204752)
8. Williams SJ, Cvetkovic D, Hamilton TC: Vitamin A metabolism is impaired in human ovarian cancer. Gynecol Oncol 2009, 112:637-645
9. Kuppumbatti YS, Bleiweiss IJ, Mandeli JP, Waxman S, Mira-y-Lopez R: Cellular retinol-binding protein expression and breast cancer. J Natl Cancer Inst 2000, 92:475-480 (Pubitemid 30182884)
10. Chang B, Liu G, Xue F, Rosen DG, Xiao L, Wang X, Liu J: ALDH1 expression correlates with favorable prognosis in ovarian cancers. Mod Pathol 2009, 22:817-823
11. Kim H, Lapointe J, Kaygusuz G, Ong DE, Li C, van DE Rijn M, Brooks JD, Pollack JR: The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res 2005, 65:8118-8124 (Pubitemid 41330574)
12. Huang Y, de la Chapelle A, Pellegata NS: Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int J Cancer 2003, 104:735-744 (Pubitemid 36418511)
13. Jing Y, Waxman S, Mira-Y-Lopez R: The cellular retinoic acid binding protein II is a positive regulator of retinoic acid signaling in breast cancer cells. Cancer Res 1997, 57:1668-1672 (Pubitemid 27199656)
14. Manor D, Shmidt EN, Budhu A, Flesken-Nikitin A, Zgola M, Page R, Nikitin AY, Noy N: Mammary carcinoma suppression by cellular retinoic acid binding protein-II. Cancer Res 2003, 63:4426-4433 (Pubitemid 36951014)
15. Schug TT, Berry DC, Shaw NS, Travis SN, Noy N: Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell 2007, 129:723-733 (Pubitemid 46802374)
16. Schug TT, Berry DC, Toshkov IA, Cheng L, Nikitin AY, Noy N: Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR. Proc Natl Acad Sci USA 2008, 105:7546-7551 (Pubitemid 351830055)
17. Karcher S, Steiner H, Ahmadi R, Zoubaa S, Vasvari G, Bauer H, Unterberg A, Herold-Mende C: Different angiogenic phenotypes in primary and secondary glioblastomas. Int J Cancer 2006, 118: 2182-2189
18. Campos B, Wan F, Farhadi M, Ernst A, Zeppernick F, Tagscherer KE, Ahmadi R, Lohr J, Dictus C, Gdynia G, Combs SE, Goidts V, Helmke BM, Eckstein V, Roth W, Beckhove P, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende C: Differentiation therapy exerts antitumor effects on stem-like glioma cells. Clin Cancer Res 2010, 16:2715-2728
19. Schmidt CK, Brouwer A, Nau H: Chromatographic analysis of endogenous retinoids in tissues and serum. Anal Biochem 2003, 315:36-48 (Pubitemid 36379104)
20. Noy N: Retinoid-binding proteins: mediators of retinoid action. Biochem J 2000, 348 Pt 3:481-495
21. Duester G: Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur J Biochem 2000, 267:4315-4324
22. Delva L, Bastie JN, Rochette-Egly C, Kraïba R, Balitrand N, Despouy G, Chambon P, Chomienne C: Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 1999, 19:7158-7167 (Pubitemid 29441896)
23. Giguère V: Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocr Rev 1994, 15:61-79
24. White RJ, Schilling TF: How degrading: cyp26s in hindbrain development. Dev Dyn 2008, 237:2775-2790
25. Napoli JL: Quantification of physiological levels of retinoic acid. Methods Enzymol 1986, 123:112-124
26. Sessler RJ, Noy N: A ligand-activated nuclear localization signal in cellular retinoic acid binding protein-II. Mol Cell 2005, 18:343-353 (Pubitemid 41350539)
27. Wan F, Herold-Mende C, Campos B, Centner FS, Dictus C, Becker N, Devens F, Mogler C, Felsberg J, Grabe N, Reifenberger G, Lichter P, Unterberg A, Bermejo JL, Ahmadi R: Association of stem cell-related markers and survival in astrocytic gliomas. Biomarkers 2011, 16:136-143
28. Strojnik T, Røsland GV, Sakariassen PO, Kavalar R, Lah T: Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. Surg Neurol 2007, 68:133-143; discussion 143-144
29. Lendahl U, Zimmerman LB, McKay RD: CNS stem cells express a new class of intermediate filament protein. Cell 1990, 60:585-595
30. Dictus C, Tronnier V, Unterberg A, Herold-Mende C: Comparative analysis of in vitro conditions for rat adult neural progenitor cells. J Neurosci Methods 2007, 161:250-258 (Pubitemid 46466951)
31. Reya T, Morrison SJ, Clarke MF, Weissman IL: Stem cells, cancer, and cancer stem cells. Nature 2001, 414:105-111 (Pubitemid 33041634)
32. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ: Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005, 65:10946-10951 (Pubitemid 41713363)
33. Al-Hajj M: Cancer stem cells and oncology therapeutics. Curr Opin Oncol 2007, 19:61-64
34. Bonnet D, Dick JE: Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997, 3:730-737 (Pubitemid 27298715)
35. Zeppernick F, Ahmadi R, Campos B, Dictus C, Helmke BM, Becker N, Lichter P, Unterberg A, Radlwimmer B, Herold-Mende CC: Stem cell marker CD133 affects clinical outcome in glioma patients. Clin Cancer Res 2008, 14:123-129 (Pubitemid 351377986)
36. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567 (Pubitemid 350056407)
37. Hess DA, Meyerrose TE, Wirthlin L, Craft TP, Herrbrich PE, Creer MH, Nolta JA: Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004, 104:1648-1655 (Pubitemid 39202270)
38. Corti S, Locatelli F, Papadimitriou D, Donadoni C, Salani S, Del Bo R, Strazzer S, Bresolin N, Comi GP: Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006, 24:975-985 (Pubitemid 44464730)
39. Pearce DJ, Taussig D, Simpson C, Allen K, Rohatiner AZ, Lister TA, Bonnet D: Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 2005, 23:752-760 (Pubitemid 40791790)
40. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, Fields JZ, Wicha MS, Boman BM: Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 2009, 69:3382-3389
41. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL: Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009, 7:330-338
42. Ma S, Chan KW, Lee TK, Tang KH, Wo JY, Zheng B, Guan X: Aldehyde dehydrogenase discriminates the CD133 liver cancer stem cell populations. Mol Cancer Res 2008, 6:1146-1153
43. Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F: ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest 2010, 90:234-244
44. Chen Y, Chen Y, Hsu H, Tseng L, Huang P, Lu K, Chen D, Tai L, Yung M, Chang S, Ku H, Chiou S, Lo W: Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 2009, 385:307-313
45. Spoorendonk KM, Peterson-Maduro J, Renn J, Trowe T, Kranenbarg S, Winkler C, Schulte-Merker S: Retinoic acid and Cyp26b1 are critical regulators of osteogenesis in the axial skeleton. Development 2008, 135:3765-3774